Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
2021 · Translational Psychiatry · 66 citations
https://doi.org/10.1038/s41398-021-01709-9
C
Craig Nelson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
2.2K
Citations
25
h-index
37
i10-index
Craig Nelson is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Psychopathy, Forensic Psychiatry, Sexual Offending & Treatment of Major Depression. The author has an h-index of 25, co-authored 58 publications.
Papers by this author
worksStaging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
2021 · Translational Psychiatry · 62 citations
https://doi.org/10.1038/s41398-021-01602-5
Somatic and anxiety symptoms of depression are associated with disability in late life depression
2019 · Aging & Mental Health · 38 citations
https://doi.org/10.1080/13607863.2019.1597013
Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
2020 · Journal of Managed Care & Specialty Pharmacy · 25 citations
https://doi.org/10.18553/jmcp.2020.20017
The Impact of Amyloid Burden and <i>APOE</i> on Rates of Cognitive Impairment in Late Life Depression
2021 · Journal of Alzheimer s Disease · 22 citations
https://doi.org/10.3233/jad-201089
Depression Severity, but Not Cognitive Impairment or Frailty, is Associated with Disability in Late-Life Depression
2019 · Clinical Gerontologist · 18 citations
https://doi.org/10.1080/07317115.2019.1699882
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat